In Los Angeles, occupational therapists tapped to help homeless stay housed

Carla Brown waits on an air mattress, eager for her occupational therapist to arrive at her apartment next to the Hollywood Freeway, mere blocks from where she once camped on the sidewalk.

GSK’s Nucala for severe eosinophilic asthma approved in China

Share this article In the 52-week trial, mepolizumab significantly reduced the annual rate of clinically significant exacerbations. Credit: Chinnapong/ shutterstock.com. GSK has received approval from

January 11, 2024

Industry and Researchers Respond to ICER Report on MDMA-Assisted Therapy, Which Maintains Lykos’ Clinical Evidence Is “Insufficient” – Psychedelic Alpha

Chief among the public comments was a brief submission from Lykos Therapeutics itself (page 1). “Lykos is disappointed by the ICER draft report as it

May 14, 2024

With IPO money, Neumora eyes deals as CEO brings M&A chops from roles at AbbVie, JP Morgan

Neumora Therapeutics, a brain disease biotech born out of stitching together multiple neuroscience startups, is looking to replicate its original playbook by complementing its seven-drug

November 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.